Connect with us

breaking news

Canada’s federal cannabis fees ‘make industry unsustainable, says Cannabis Council of Canada,

Published

on


MJ Biz reports

Canadian cannabis executives are pleading with the federal government to offer relief to the fee and excise regime it imposes on the industry amid mounting job and financial losses.

The executives warned during a Wednesday news conference that without meaningful reform, more communities in Canada would face job losses such as those recently announced by Canopy Growth Corp. and others.

So far this year, Canadian cannabis producers have announced almost 1,000 job cuts, including:

  • 800 employees by Canopy in Smiths Falls, Ontario.
  • 85 jobs in Olds, Alberta, by Calgary-based producer and retailer SNDL.
  • 40 positions by Ontario-headquartered Aleafia Health.
  • 40 staff by Winnipeg, Manitoba-based Delta 9 Cannabis.

“We’ve seen in Smiths Falls, Ontario, and Olds, Alberta, the consequences of an administration of fees and taxes which makes our industry largely unsustainable,” George Smitherman, CEO of the industry group Cannabis Council of Canada, said during the news conference in Ottawa.

“Everywhere you look, someone’s put up a fee or a regulatory barrier or burden that in the collective sense is making it impossible for our sector to make the progress that was expected and sustainable in the long run.”

He would like to see an easing in the regulatory fee, which currently charges standard cultivation licensees 2.3% of their annual gross revenue from cannabis, or 23,000 Canadian dollars ($17,200), whichever is higher.

“The budget presents an opportunity for the government of Canada to send a message about its commitment to the sustainability of our sector,” Smitherman said.

Read more at

https://mjbizdaily.com/canada-federal-cannabis-fees-make-industry-unsustainable-group-says/



Source link

Continue Reading

breaking news

Massachusetts: Office of the Inspector General Publishes Press Release Re Appointing A Receiver To Manage State’s Cannabis Commission

Published

on

By


Independent journalist Grant Smith Ellis  writes today to linked in

Press release from Massachusetts Inspector General confirms that a decision in June of 2024, by three CCC Commissioners, to strip the powers of acting agency Executive Director Debbie Hilton-Creek led to today’s emergency hearing request on Beacon Hill.

 



Source link

Continue Reading

breaking news

Movie Time In Oregon. Special Screening of Frenchy Dreams of Hashish

Published

on

By


CHEECHABLE & OG EMPIRE PRESENT:

A SPECIAL 7/10 with FRENCHY CANNOLI! We are pleased to announce a special screening and Oregon premier of the movie Frenchy Dreams of Hashish, a documentary by Jake Remington. Frenchy Dreams of Hashish showcases master hashishin Frenchy Cannoli’s lifelong pursuit of perfect hashish and highlights the ethos of sustainable, sun-grown cannabis. Join us as we celebrate the art of making hash and honor the late master, Frenchy Cannoli. Get your tickets here!

 



Source link

Continue Reading

breaking news

Curaleaf Start Process Of Getting Their Claws Into The UK’s National Health System – With Former MP (Resigned Today 30/5/24) As The Front Man

Published

on

By


It’ll take a while but the business plan to get Curaleaf products available via the NHS starts here…and the front man is  now former Conservative MP George Freeman

See the press release dated 28 May (scroll down)  about his involvement and and what a surprise

30 May 2024

George Freeman is no longer a Member, but was most recently the Conservative MP for Mid Norfolk, and left the Commons on 30 May 2024.

https://members.parliament.uk/member/4020/career

 

 

 

Positioned at the heart of the life sciences sector, the Cannabinoid Research & Development Group UK is a new research strategy group led by academics, researchers, clinicians, patients and industry.

The group will propel scientific research and development of pharmaceutical cannabinoid-related products in the UK.

Our ambition is to develop and implement a comprehensive strategy to transform the UK into the global leader in cannabinoid research and medicine development.

We will build a robust ecosystem by integrating universities, research institutions, investors, businesses, and the NHS – driving innovation and development, nurturing top talent and fostering advances in healthcare.

 

 



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media